• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖作为结直肠癌手术后围手术期和术后结局的决定因素:一项基于人群的研究(2009-2016 年)。

Obesity as a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery: A population-based study (2009-2016).

机构信息

Department of Surgery, Leiden University Medical Center, Leiden, Netherlands; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, Netherlands.

Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.

出版信息

Eur J Surg Oncol. 2018 Dec;44(12):1849-1857. doi: 10.1016/j.ejso.2018.05.027. Epub 2018 Jun 6.

DOI:10.1016/j.ejso.2018.05.027
PMID:29937416
Abstract

BACKGROUND

Obesity is an increasing problem worldwide that can influence perioperative and postoperative outcomes. However, the relationship between obesity and treatment-related perioperative and short-term postoperative morbidity after colorectal resections is still subject to debate.

STUDY

Patients were selected from the DCRA, a population-based audit including 83 hospitals performing colorectal cancer (CRC) surgery. Data regarding primary resections between 2009 and 2016 were eligible for analyses. Patients were subdivided into six categories: underweight, normal weight, overweight and obesity class I, II and III.

RESULTS

Of 71,084 patients, 17.7% with colon and 16.4% with rectal cancer were categorized as obese. Significant differences were found for the 30-day overall postoperative complication rate (p < 0.001), prolonged hospitalization (p < 0.001) and readmission rate (colon cancer p < 0.005; rectal cancer p < 0.002) in obese CRC patients. Multivariate analysis identified BMI ≥30 kg/m as independent predictor of a complicated postoperative course in CRC patients. Furthermore, obesity-related comorbidities were associated with higher postoperative morbidity, prolonged hospitalization and a higher readmission rate. No significant differences in performance were observed in postoperative outcomes of morbidly obese CRC patients between hospitals performing bariatric surgery and hospitals that did not.

CONCLUSION

The real-life data analysed in this study reflect daily practice in the Netherlands and identify obesity as a significant risk factor in CRC patients. Obesity-related comorbidities were associated with higher postoperative morbidity, prolonged hospitalization and a higher readmission rate in obese CRC patients. No differences were observed between hospitals performing bariatric surgery and hospitals that did not.

摘要

背景

肥胖是一个全球性的日益严重的问题,会影响围手术期和术后结果。然而,肥胖与结直肠切除术后相关的围手术期和短期术后发病率之间的关系仍存在争议。

研究

该研究从 DCRA 中选择患者,该研究是一项基于人群的审计,包括 83 家进行结直肠癌(CRC)手术的医院。符合分析条件的数据是 2009 年至 2016 年间的原发性切除术数据。患者被分为六类:体重不足、正常体重、超重和肥胖 I 级、II 级和 III 级。

结果

在 71084 名患者中,17.7%的结肠癌和 16.4%的直肠癌患者被归类为肥胖。肥胖 CRC 患者的 30 天总体术后并发症发生率(p<0.001)、住院时间延长(p<0.001)和再入院率(结肠癌 p<0.005;直肠癌 p<0.002)存在显著差异。多变量分析确定 BMI≥30kg/m2是 CRC 患者术后并发症的独立预测因素。此外,肥胖相关合并症与更高的术后发病率、住院时间延长和更高的再入院率相关。在接受减重手术的医院和未接受减重手术的医院之间,肥胖 CRC 患者术后结局的表现没有显著差异。

结论

本研究分析的真实数据反映了荷兰的日常实践,并确定肥胖是 CRC 患者的一个重要危险因素。肥胖相关合并症与肥胖 CRC 患者更高的术后发病率、住院时间延长和更高的再入院率相关。在接受减重手术的医院和未接受减重手术的医院之间,没有观察到差异。

相似文献

1
Obesity as a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery: A population-based study (2009-2016).肥胖作为结直肠癌手术后围手术期和术后结局的决定因素:一项基于人群的研究(2009-2016 年)。
Eur J Surg Oncol. 2018 Dec;44(12):1849-1857. doi: 10.1016/j.ejso.2018.05.027. Epub 2018 Jun 6.
2
Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.荷兰筛查检出与非筛查检出结直肠癌的术后结局比较。
JAMA Surg. 2018 Dec 1;153(12):e183567. doi: 10.1001/jamasurg.2018.3567. Epub 2018 Dec 19.
3
The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer.荷兰结直肠癌患者体重指数与术后并发症、30 天死亡率和长期生存率的关系。
Eur J Surg Oncol. 2019 Feb;45(2):160-166. doi: 10.1016/j.ejso.2018.09.012. Epub 2018 Oct 16.
4
Morbid Obesity is Associated with Increased Mortality, Surgical Complications, and Incremental Health Care Utilization in the Peri-Operative Period of Colorectal Cancer Surgery.病态肥胖与结直肠癌手术围手术期死亡率增加、手术并发症及医疗保健利用率增加相关。
World J Surg. 2016 Apr;40(4):987-94. doi: 10.1007/s00268-015-3358-0.
5
Factors associated with outcomes and inpatient 90-day cost of care in endometrial cancer patients undergoing hysterectomy - implications for bundled care payments.接受子宫切除术的子宫内膜癌患者的结局和住院 90 天护理费用的相关因素——对捆绑式护理支付的影响。
Gynecol Oncol. 2018 Jul;150(1):106-111. doi: 10.1016/j.ygyno.2018.05.010.
6
The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer.肥胖对子宫内膜癌手术后30天发病率和死亡率的影响。
J Minim Invasive Gynecol. 2015 Jan;22(1):94-102. doi: 10.1016/j.jmig.2014.07.014. Epub 2014 Jul 24.
7
The relationship between body mass index, sex, and postoperative outcomes in patients undergoing potentially curative surgery for colorectal cancer.接受结直肠癌潜在根治性手术患者的体重指数、性别与术后结局之间的关系。
Clin Nutr ESPEN. 2019 Apr;30:185-189. doi: 10.1016/j.clnesp.2018.12.084. Epub 2019 Jan 11.
8
Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan.BMI 对乳腺癌手术后结局的影响:日本全国住院患者数据库研究。
Clin Breast Cancer. 2020 Dec;20(6):e663-e674. doi: 10.1016/j.clbc.2020.05.002. Epub 2020 May 11.
9
Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial.术前老年综合评估及个体化干预在结直肠癌虚弱老年患者中的应用:一项随机对照试验。
Colorectal Dis. 2018 Jan;20(1):16-25. doi: 10.1111/codi.13785.
10
Successful and safe introduction of laparoscopic colorectal cancer surgery in Dutch hospitals.荷兰医院成功且安全地开展腹腔镜结直肠癌手术。
Ann Surg. 2013 May;257(5):916-21. doi: 10.1097/SLA.0b013e31825d0f37.

引用本文的文献

1
Impact of obesity on the short-term outcomes of robotic surgery for rectal cancer: a Japanese multicenter study.肥胖对直肠癌机器人手术短期结局的影响:一项日本多中心研究。
Surg Today. 2025 Aug 22. doi: 10.1007/s00595-025-03116-9.
2
Pancreas-guided C-shaped surgical procedure: a safer and more efficient procedure for laparoscopic left hemicolectomy in obese patients.胰腺引导下C形手术:肥胖患者腹腔镜左半结肠切除术更安全、更有效的手术方式。
Updates Surg. 2025 Apr;77(2):343-353. doi: 10.1007/s13304-025-02071-x. Epub 2025 Jan 18.
3
Development and validation of machine learning models and nomograms for predicting the surgical difficulty of laparoscopic resection in rectal cancer.
开发和验证用于预测直肠癌腹腔镜切除手术难度的机器学习模型和列线图。
World J Surg Oncol. 2024 Apr 25;22(1):111. doi: 10.1186/s12957-024-03389-3.
4
The short- and long-term readmission of four major categories of digestive system cancers: does obesity or metabolic disorder matter?消化系统四大类癌症的短期和长期再入院率:肥胖或代谢紊乱是否重要?
Front Endocrinol (Lausanne). 2023 Oct 30;14:1214651. doi: 10.3389/fendo.2023.1214651. eCollection 2023.
5
Impact of obesity on patients undergoing surgery for rectal cancer in Australia and New Zealand.肥胖对在澳大利亚和新西兰接受直肠癌手术的患者的影响。
Int J Colorectal Dis. 2023 Jun 8;38(1):163. doi: 10.1007/s00384-023-04447-0.
6
Intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy: a retrospective study.腹腔镜右半结肠切除术的体内吻合与体外吻合:一项回顾性研究。
World J Surg Oncol. 2023 May 20;21(1):154. doi: 10.1186/s12957-023-03023-8.
7
Robotic-assisted versus laparoscopic rectal surgery in obese and morbidly obese patients: ACS-NSQIP analysis.机器人辅助与腹腔镜直肠手术治疗肥胖和病态肥胖患者:ACS-NSQIP 分析。
J Robot Surg. 2023 Apr;17(2):637-643. doi: 10.1007/s11701-022-01462-1. Epub 2022 Oct 21.
8
Effect of obesity on post-operative outcomes following colorectal cancer surgery.肥胖对结直肠癌手术后术后结局的影响。
World J Gastrointest Oncol. 2022 Jul 15;14(7):1324-1336. doi: 10.4251/wjgo.v14.i7.1324.
9
Association between diabetes, obesity, aging, and cancer: review of recent literature.糖尿病、肥胖、衰老与癌症之间的关联:近期文献综述
Transl Cancer Res. 2020 Sep;9(9):5743-5759. doi: 10.21037/tcr.2020.03.14.
10
-mediated colon cancer cell proliferation and dissemination is regulated by miR-221-3p.- 介导的结肠癌细胞增殖和扩散受miR-221-3p调控。
Transl Cancer Res. 2019 Aug;8(4):1289-1300. doi: 10.21037/tcr.2019.07.12.